Health & Fitness

OncLive® On Air

by OncLive® On Air

Claiming needs an RSS feed. Contact us.

Listen on Apple Podcasts

Chart positions today · India

Not on the India charts we track today.

If you like OncLive® On Air, try…

On Target

Ranking history · India

Health & Fitness · History only

Latest daily rankings: Oct 22. New rankings will appear after the next update.

Recent history only — this show has no current ranking on the Health & Fitness, India chart. These are recorded positions from the last 7 days, not current rankings.

Position on the Health & Fitness, India combined chart over the last 7 days. Toggle platforms to compare their positions. Lower rank numbers are better.

View as table

Date	Combined Rank	Apple Podcasts
Oct 22	—	—
Oct 19	#154	#154

Latest episodes

Weigh Benefit Against Burden: Defining Lurbinectedin’s Role in a Shifting Small Cell Lung Cancer Landscape

October 19, 2026 · 22 min

In today’s episode, we spoke with Triparna Sen, PhD, and Jacob Sands, MD. Dr Sen is a professor of internal medicine and the director of the Lung Cancer Preclinical Therapeutics Platform at the Ohio State University Comprehensive Cancer…
FDA Approval Insights: First-Line Maintenance Tucatinib/Trastuzumab/Pertuzumab in Advanced HER2+ Breast Cancer

October 16, 2026 · 11 min

In today’s episode, we spoke with Erika P. Hamilton, MD, about the FDA approval of tucatinib (Tukysa) plus trastuzumab (Herceptin) and pertuzumab (Perjeta) for the maintenance treatment of adult patients with unresectable locally advanced…
Biology-Driven Care and AI Tools Steer the Future of Breast Oncology

October 15, 2026 · 27 min

In this episode of Oncology Unplugged, host Chandler Park, MD, MSc, FACP, a medical oncologist at Norton Cancer Institute in Louisville, Kentucky, was joined by Jame Abraham, MD, FACP, the enterprise chairman of the Department of…
Subcutaneous, On-Body Administration Opens Potential Door for At-Home Treatment in Multiple Myeloma

October 14, 2026 · 11 min

In this episode, produced in coordination with Oncology Nursing News®, Beth Faiman, PhD, MSN, APN-BC, AOCN, FAAN, FAPO, and Sikander Ailawadhi, MD, discussed how on-body subcutaneous administration methods could allow for select at-home…
Sequencing B7-H4–Targeted ADCs and Optimizing Toxicity Management in Gynecologic Cancers

October 14, 2026 · 16 min

In today’s episode, we spoke with Angeles Alvarez Secord, MD, MHSc. Dr Secord is a professor of obstetrics and gynecology and a member of Duke Cancer Institute in Durham, North Carolina. In our exclusive interview, Dr Secord discussed the…

Show 7 more episodesShow fewer episodes

The Next Wave: ADCs, Targeted Therapies, and Emerging Strategies in Ovarian Cancer

October 14, 2026 · 34 min

From Discovery to Delivery: Charting Progress in Gynecologic Oncology, hosted by Ursula A. Matulonis, MD, brings expert insights into the most recent breakthroughs, evolving standards, and emerging therapies across gynecologic cancers. Dr…
Navigating Patient-Centric Treatment Administration Strategies in Myeloma

October 9, 2026 · 9 min

In this episode, produced in coordination with Oncology Nursing News®, Beth Faiman, PhD, MSN, APN-BC, AOCN, FAAN, FAPO, and Sikander Ailawadhi, MD, discussed how on-body subcutaneous administration methods are affecting multiple myeloma…
Novel MEK inhibitor Research Aims to Balance Efficacy and Tolerability in Pancreatic Cancer

October 7, 2026 · 11 min

In today’s episode, we spoke with Vincent Chung, MD, about the development of atebimetinib (IMM-1-104) in metastatic pancreatic cancer. Dr Chung is a professor in the Department of Medical Oncology & Therapeutics Research at City of Hope…
FDA Approval Insights: Ropeginterferon Alfa-2b Ushers in Long-Awaited New Treatment Option for Essential Thrombocythemia

October 2, 2026 · 13 min

In today’s episode, we welcomed Ruben Mesa, MD, FACP, who outlined the significance of the August 2026 FDA approval of ropeginterferon alfa-2b-njft (Besremi) for the treatment of adult patients with essential thrombocythemia. Dr Mesa is…
FDA Approval Insights: Daraxonrasib for Metastatic Pancreatic Ductal Adenocarcinoma

September 30, 2026 · 12 min

In today’s episode, we spoke with Kim A. Reiss Binder, MD, about the August 2026 FDA approval of daraxonrasib (Rasonque) for the treatment of adult patients with metastatic pancreatic adenocarcinoma who have received at least 1 prior…
Resistance Patterns Shape FGFR Inhibitor Sequencing in Cholangiocarcinoma

September 30, 2026 · 16 min

In this episode, we spoke with Arndt Vogel, MD, a faculty member at the University of Toronto Institute of Medical Science, a scientist at the Toronto General Hospital Research Institute, and a medical oncologist at the UHN–Princess…
Subcutaneous Therapies Bolster Administration Options in Multiple Myeloma

September 30, 2026 · 14 min

In this episode, produced in coordination with Oncology Nursing News®, Beth Faiman, PhD, MSN, APN-BC, AOCN, FAAN, FAPO, and Sikander Ailawadhi, MD, discussed evolving administration strategies for multiple myeloma therapies, primarily…

Full episode archive on Apple Podcasts →

About the show

In OncLive® On Air, you can expect to hear interviews with academic oncologists on the thought-provoking oncology presentations they give at the OncLive® State of the Science Summits. The topics in oncology vary, from systemic therapies, surgery, radiation therapy, to emerging therapeutic approaches in a particular type of cancer. This includes lung cancer, breast cancer, gastrointestinal cancers, hematologic malignancies, gynecologic cancers, genitourinary cancers, and more.